Id |
Subject |
Object |
Predicate |
Lexical cue |
T82 |
0-12 |
Sentence |
denotes |
Who to Test: |
T83 |
13-68 |
Sentence |
denotes |
Current Diagnostic Recommendations in the United States |
T84 |
69-274 |
Sentence |
denotes |
In response to the rapidly evolving COVID-19 pandemic, countries have used different testing approaches depending on testing capacity, public health resources, and the spread of the virus in the community. |
T85 |
275-451 |
Sentence |
denotes |
In the United States, diagnostic testing indications and capacity were limited at the beginning of the outbreak, largely because of regulatory hurdles for the use of new tests. |
T86 |
452-588 |
Sentence |
denotes |
To expand access to testing, the FDA released policies to allow laboratories to use their validated assays in a more timely manner (27). |
T87 |
589-793 |
Sentence |
denotes |
On 4 March, the Centers for Disease Control and Prevention (CDC) removed restrictive testing criteria, recommending that clinicians use their judgment to determine whether a test should be performed (28). |
T88 |
794-906 |
Sentence |
denotes |
Because testing capacity remains suboptimal (27), the implementation of this recommendation remains a challenge. |
T89 |
907-1252 |
Sentence |
denotes |
The CDC still recommends priority for testing 3 groups: hospitalized patients with presentations compatible with COVID-19, other symptomatic persons at risk for poor outcomes, and persons who had close contact with someone with suspected or confirmed COVID-19 within 14 days of illness onset or have a history of travel in an affected area (28). |
T90 |
1253-1341 |
Sentence |
denotes |
These patients should be evaluated with a molecular diagnostic test, as described later. |
T91 |
1342-1398 |
Sentence |
denotes |
The CDC does not recommend testing asymptomatic persons. |